XLV vs. ARKK
XLV (State Street Health Care Select Sector SPDR ETF) and ARKK (ARK Innovation ETF) are both exchange-traded funds - XLV is a Health & Biotech Equities fund tracking the Health Care Select Sector Index, while ARKK is a Technology Equities fund actively managed by ARK. XLV is passively managed, while ARKK is actively managed. Over the past 10 years, XLV returned 9.64%/yr vs 14.94%/yr for ARKK. At a 0.44 correlation, their price movements are largely independent. XLV charges 0.08%/yr vs 0.75%/yr for ARKK.
Performance
XLV vs. ARKK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XLV achieves a 3.75% return, which is significantly higher than ARKK's -2.56% return. Over the past 10 years, XLV has underperformed ARKK with an annualized return of 9.64%, while ARKK has yielded a comparatively higher 14.94% annualized return.
XLV
- 1D
- -1.14%
- 1M
- 7.06%
- 6M
- 3.13%
- YTD
- 3.75%
- 1Y
- 22.90%
- 3Y*
- 7.12%
- 5Y*
- 6.00%
- 10Y*
- 9.64%
- ALL TIME*
- 8.56%
ARKK
- 1D
- -0.33%
- 1M
- -6.53%
- 6M
- -8.24%
- YTD
- -2.56%
- 1Y
- -3.45%
- 3Y*
- 16.39%
- 5Y*
- -9.13%
- 10Y*
- 14.94%
- ALL TIME*
- 12.69%
XLV vs. ARKK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XLV State Street Health Care Select Sector SPDR ETF | 3.75% | 14.50% | 2.47% | 2.07% | -2.08% | 26.04% | 13.30% | 20.45% | 6.28% | 21.77% |
ARKK ARK Innovation ETF | -2.56% | 35.49% | 8.40% | 69.04% | -66.97% | -23.60% | 152.71% | 35.08% | 3.52% | 87.33% |
Correlation
The correlation between XLV and ARKK is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.35 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Oct 31, 2014 | 0.44 |
Over the past year, the correlation between XLV and ARKK has dropped to 0.17 - well below their long-term average of 0.44, suggesting their price drivers have been diverging.
XLV vs. ARKK - Sectors Allocation Comparison
Sectors
XLV
ARKK
Healthcare
Basic Materials
-
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
XLV
ARKK
Basic Materials
XLV
-
ARKK
-
Communication Services
XLV
-
ARKK
Consumer Cyclical
XLV
-
ARKK
Consumer Defensive
XLV
-
ARKK
-
Energy
XLV
-
ARKK
-
Financial Services
XLV
-
ARKK
Industrials
XLV
-
ARKK
Real Estate
XLV
-
ARKK
-
Technology
XLV
-
ARKK
Utilities
XLV
-
ARKK
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XLV vs. ARKK — Risk / Return Rank
XLV
ARKK
XLV vs. ARKK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and ARK Innovation ETF (ARKK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XLV | ARKK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.55 | ||
| Sortino ratioReturn per unit of downside risk | +2.17 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.01 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 2.20 | -0.11 | +2.31 |
| Martin ratioReturn relative to average drawdown | 5.19 | -0.23 | +5.42 |
Loading charts...
Drawdowns
XLV vs. ARKK - Drawdown Comparison
The maximum XLV drawdown since its inception was -39.17%, smaller than the maximum ARKK drawdown of -80.97%. Use the drawdown chart below to compare losses from any high point for XLV and ARKK.
Loading charts...
Drawdown Indicators
| XLV | ARKK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -39.17% | -80.97% | +41.80% |
Max Drawdown (1Y)Largest decline over 1 year | -10.47% | -31.35% | +20.88% |
Max Drawdown (3Y)Largest decline over 3 years | -17.11% | -39.56% | +22.45% |
Max Drawdown (5Y)Largest decline over 5 years | -17.11% | -76.27% | +59.16% |
Max Drawdown (10Y)Largest decline over 10 years | -28.40% | -80.97% | +52.57% |
Current DrawdownCurrent decline from peak | -3.16% | -51.47% | +48.31% |
Average DrawdownAverage peak-to-trough decline | -7.10% | -30.31% | +23.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.42% | 15.08% | -10.66% |
Volatility
XLV vs. ARKK - Volatility Comparison
The current volatility for State Street Health Care Select Sector SPDR ETF (XLV) is 6.35%, while ARK Innovation ETF (ARKK) has a volatility of 9.21%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than ARKK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XLV | ARKK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.35% | 9.21% | -2.86% |
Volatility (6M)Calculated over the trailing 6-month period | 11.91% | 27.14% | -15.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.86% | 36.37% | -20.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.98% | 46.49% | -31.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.63% | 40.43% | -23.80% |
XLV vs. ARKK - Expense Ratio Comparison
XLV has a 0.08% expense ratio, which is lower than ARKK's 0.75% expense ratio.
Dividends
XLV vs. ARKK - Dividend Comparison
XLV's dividend yield for the trailing twelve months is around 1.59%, while ARKK has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKK ARK Innovation ETF | 0.00% | 0.00% | 0.00% | 0.70% | 0.00% | 0.55% | 1.64% | 0.38% | 3.14% | 1.32% | 0.00% | 2.27% |
XLV State Street Health Care Select Sector SPDR ETF | 1.59% | 1.60% | 1.67% | 1.59% | 1.47% | 1.33% | 1.49% | 2.17% | 1.57% | 1.47% | 1.60% | 1.43% |
Frequently Asked Questions
XLV and ARKK have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKK has higher volatility (9.21%) compared to XLV (6.35%). In terms of maximum drawdown, XLV dropped -39.17% vs ARKK's -80.97%.
On 10-year performance, ARKK leads with 14.94% vs 9.64% for XLV. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 6.35%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, ARKK has performed better with a 14.94% return vs 9.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XLV is cheaper with a 0.08% expense ratio, compared with 0.75% for ARKK.
XLV has the higher dividend yield at 1.59%, compared with 0.00% for ARKK.
XLV is categorized as Health & Biotech Equities, while ARKK is Technology Equities. They also come from different issuers: State Street and ARK. Their fees differ too: 0.08% for XLV and 0.75% for ARKK.
XLV currently has the higher Sharpe Ratio (1.45 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XLV and ARKK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer